Clinical Trial: Safety and Efficacy of Faricimab in Patients With NPDR
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-Proliferative Diabetic Retinopathy
Study Type: INTERVENTIONAL
Official Title: Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy: The MAGIC Phase 2, Multi-Center, Open-Label, Randomized Controlled Trial
Brief Summary:
The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Proliferative Diabetic Retinopathy.
Read more